Jeff Sharman, MD, a medical oncologist at the Willamette Ballet Cancer Institute and Research Center,…

Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…

By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…

In an ongoing Phase 1/2 study, Constantine Tam, MD, a researcher and Professor of Haematology,…

In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

By: Hope Rugo, MD Date: 12/9/2023 At the SABCS 2023 conference, medical oncologist Hope Rugo…

By. Valeria Santini, MDDate: 12/13/2023At the ASH 2023 symposium, Valeria Santini, MD, a distinguished medical…

Hamish Scott, MD, serves as the Head of the Department of Genetics and Molecular Pathology…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

By: Yara Abdou, MD, Date. 12/08/2023 At SABCS 2023, Yara Abdou, MD, a medical oncologist…